REGISTERED ONLINE PHARMACY
NHS registered UK Doctors.
COMPLETELY SECURE SERVICE
Your information is in safe hands
FAST, FREE, DISCREET SHIPPING
On all standard orders over £40
Monday, March 24, 2025
Mounjaro (tirzepatide) has been used to treat diabetes since 2022, but its approval as a weight loss medication is much more recent (1). With its rollout on the NHS having started in 2024 (2), many people are asking the same question: Is Mounjaro safe?
The short answer? Yes, for most people, it’s safe and well-tolerated. While Mounjaro might be new to the market, it belongs to a well-studied group of drugs called GLP-1 receptor agonists, which have been used for nearly two decades. This means we already have a wealth of safety data from similar medications, as well as rigorous clinical trials that specifically tested Mounjaro.
So, what does the research say? Let’s take a closer look.
Mounjaro is generally safe and well-tolerated (3). It may be a new weight loss medication for 2025, but GLP-1s have been used for years. The first GLP-1 drug for diabetes was approved in 2006, and the first GLP-1 drug for weight loss was Saxenda (Liraglutide) in 2014, followed by Wegovy.
Although these are different drugs, they work on the same GLP-1 receptors in the body, so we already know a lot about how they affect metabolism, digestion, and long-term health. However, Mounjaro is slightly different; it targets not only GLP-1 receptors but also another type of receptor called GIP (glucose-dependent insulinotropic polypeptide) receptors (4).
The dual action is what makes Mounjaro more effective than other weight loss injections (5), but it also gives it a slightly different safety profile compared to regular GLP-1s. But rest assured, before any new drug is approved in the UK, it must pass rigorous testing to meet safety standards set by the MHRA (6). Mounjaro was tested on thousands before approval, ensuring it is safe and effective.
Mounjaro was first studied as a diabetes medication in over 6,200 patients across multiple trials, known as SURPASS 1 to 5 (4, 7-11). The results showed it significantly lowered blood sugar and led to noticeable weight loss, even though weight loss wasn’t the primary focus of these studies.
The weight loss seen in the SURPASS trials led researchers to look at the potential of Mounjaro as a weight loss drug in a new set of large-scale studies called SURMOUNT 1 and 2:
In both studies, participants taking Mounjaro lost significantly more weight than those taking a placebo, with some losing up to almost 22% of their body weight (12). Tirzepatide was also well-tolerated, with mostly mild digestive side effects and no major safety concerns (12-13).
These findings confirmed that Mounjaro is both safe and effective for weight loss, leading to its approval as a weight loss treatment.
While Mounjaro is considered safe, it’s not suitable for everyone. According to NICE guidelines (14), Mounjaro is only recommended for adults who:
There are also groups who should absolutely avoid taking Mounjaro, such as pregnant or breastfeeding women (due to lack of safety data) or those with severe kidney or liver disease (15).
Before prescribing Mounjaro, doctors will assess your medical history, current medications, and overall health to ensure it’s a safe option for you. It’s also essential to follow the correct Mounjaro dose, starting with a lower dose and gradually increasing to allow your body to adjust.
Because Mounjaro is relatively new as a weight loss drug, long-term safety data is still limited. However, no major safety concerns have been identified so far. Many people continue taking Mounjaro long-term if they keep seeing results, while others may stop once they reach a healthy weight.
NICE also recommends that if a person hasn’t lost at least 5% of their starting weight after six months, treatment should be reassessed, as the Mounjaro risks may outweigh the benefits (14).
Like all medications, Mounjaro has potential side effects. Fortunately, the most common ones—such as nausea, vomiting, diarrhoea, constipation, heartburn, and headaches—are mild and usually improve over the first month of tirzepatide as your body gets used to the medication.
That said, there are some rare but serious Mounjaro risks, including:
Mounjaro can also interfere with other medications because it slows down digestion, which may affect how some oral drugs are absorbed (15).
You can find the full list of side effects in the patient information leaflet. Your prescribing team will help you understand any risks based on your medical history.
For most people who meet the criteria, Mounjaro is a safe and effective weight treatment but only when used correctly and prescribed by a licensed healthcare provider.
If you’re considering Mounjaro for weight management, here’s what to keep in mind:
If you’re considering weight loss treatment, Oxford Online Pharmacy offers expert consultations with UK-licensed doctors. All prescriptions are safely managed through the online doctor service, giving you real advice from real professionals discreetly and conveniently.
Start your consultation today, or view our weight loss treatments for more information.